Summary

for people ages 18-65 (full criteria)
healthy people welcome
at UCLA
study started
estimated completion:

Description

Summary

Two percent of all patients presenting to the Emergency Departments have complaints involving the eye. Corneal abrasions are a common diagnosis with patients with eye pain and often cause significant discomfort. Current treatment includes a thorough evaluation of the eye followed by patching, empiric antibiotics, cycloplegics and oral pain medicines. This study will be a randomized controlled trial to determine the safety and efficacy of BCLs. It will involve the initial patient evaluation followed by a return visit to the Emergency Department within 36 hours for re-examination. At each visit, the patient will be assessed for the size and location of the abrasion along with their report of pain using a visual analog scale. Data will be recorded on a standard data collection sheet. Telephone contact will be made at 30 days to ensure resolution of abrasion and that no complications ensued.

Official Title

Bandage Contact Lenses to Decrease Pain and Improve Healing in Emergency Department Subjects Presenting With Corneal Abrasions

Keywords

Corneal Abrasion Eye Trauma contact lens Eye Injuries Hydrocodone Ophthalmic Solutions Bandage contact lens Eyedrop

Eligibility

You can join if…

Open to people ages 18-65

  • Subjects between ages 18-65 years who present to the emergency department.
  • Traumatic corneal abrasion not associated with contact lens use or communicating or adjacent wounds to the eye.

You CAN'T join if...

  • Pregnant women
  • Breast-feeding women
  • Corneal abrasion associated with the wearing contact lenses
  • Evidence of corneal ulcer, glaucoma or other ocular pathology, monocular vision
  • Wound healing deficits such as collagen vascular disease or concomitant steroid use
  • Use of other ocular medications, dry eyes, blepharitis
  • Systemic infections
  • Known allergies to medicines used in the study

Location

  • Harbor-UCLA Medical Center accepting new patients
    Torrance California 90502 United States

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Los Angeles Biomedical Research Institute
ID
NCT03206723
Phase
Phase 2
Study Type
Interventional
Last Updated